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All reactions were carried out with dry, freshly distilled solvents in anhydrous 
conditions. All chemicals were used without further purification as commercially 
available unless otherwise noted. Thin-layer chromatography (TLC) was performed 
on silica gel plates (60F-254) using UV-light (254 and 365 nm). Flash 
chromatography was conducted on silica gel (300-400 mesh). NMR (400 MHz for 1H 
NMR, 100 MHz for 13C NMR) spectra were recorded in CDCl3 with TMS as the 
internal standard. High resolution mass spectral (HRMS) analyses were measured 
using ESI techniques. UV detection was monitored at 254 nm. IR spectra were 
measured using IRPrestige-21. 
A variety of 2-arylidene-1,3-indandiones 1 were synthesized via Knoevenagel 
reactions as reported in the literature,1 and azomethine imine 2 was prepared using 
general procedures reported in the literature.2 

















To a stirred mixture of 2-arylidene-1,3-indandiones 1 (0.3 mmol) and azomethine 
imine 2 (0.36 mmol) in MeOH (2 mL) was added Et3N (5 mol %) and then kept at 
room temperature for the time given, which was monitored by TLC. After removal of 
the solvent, the crude residue was purified by column chromatography (petroleum 







 Prepared according to general procedure to afford 3aa (120 mg, 
98% yield) as a white solid; m.p. 164-165 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.97 (d, J = 7.6 Hz, 1H), 7.72–7.68 (m, 
1H), 7.58–7.55 (m, 1H), 7.38 (d, J = 7.6 Hz, 1H), 7.19–7.18 (m, 
2H), 7.16–7.06 (m, 8H), 5.81 (s, 1H), 4.42 (s, 1H), 3.85–3.79 
(m, 1H), 3.10–3.02 (m, 2H), 2.94–2.87 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 
198.3, 194.6, 172.5, 143.1, 141.3, 136.4, 135.6, 135.2, 131.6, 128.8, 128.5, 128.4, 
127.8, 127.7, 125.7, 123.3, 123.2, 77.4, 72.1, 63.3, 48.2, 32.5; HRMS (ESI): m/z 
calcd for C26H20N2NaO3 [M+Na]
+ 431.1372, Found 431.1366. IR υ max: 3431, 2943, 
1746, 1711, 1587, 1260, 1233, 764, 700 cm-1. 
3'-(4-Fluorophenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a
]pyrazole]-1,3,5'(3'H)-trione (3ba) 
Prepared according to general procedure to afford 3ba (96 mg, 
75% yield) as a white solid; m.p. 155-157 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.97 (d, J = 7.6 Hz, 1H), 7.74–7.70 (m, 
1H), 7.62–7.58 (m, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.19–7.16 (m, 
2H), 7.12–7.06 (m, 5H), 6.87–6.82 (m, 2H), 5.76 (s, 1H), 4.40 
(s, 1H), 3.85–3.78 (m, 1H), 3.11–3.01 (m, 2H), 2.94–2.85 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 198.1, 194.6, 172.6, 
163.4 (JC-F = 245.2 Hz), 143.0, 141.2, 136.4, 135.7, 131.5, 130.9 (JC-F = 3.3 Hz), 
128.9, 128.5, 127.8, 127.7 (JC-F = 8.3 Hz), 123.3, 123.2, 115.6 (JC-F = 22.2 Hz), 72.0, 
62.7, 48.2, 32.5; HRMS (ESI): m/z calcd for C26H19FN2NaO3 [M+Na]
+ 449.1277, 
Found 449.1272. IR υ max: 3210, 3059, 2926, 1657, 1603, 1508, 1233, 758, 694 cm-1. 
3'-(4-Chlorophenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a
]pyrazole]-1,3,5'(3'H)-trione (3ca) 
Prepared according to general procedure to afford 3ca (112 mg, 
85% yield) as a white solid; m.p. 157-158 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.97 (d, J = 7.6 Hz, 1H), 7.74–7.70 (m, 
1H), 7.62–7.58 (m, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.18–7.09 (m, 
7H), 7.05–7.03 (m, 2H), 5.75 (s, 1H), 4.39 (s, 1H), 3.85–3.79 
(m, 1H), 3.11–3.01 (m, 2H), 2.93–2.85 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ (ppm) 197.9, 194.5, 172.7, 143.0, 141.2, 136.5, 
135.7, 133.8, 133.7, 131.4, 128.9, 128.7, 128.6, 127.8, 127.3, 123.3, 77.5, 71.9, 62.6, 
48.1, 32.4; HRMS (ESI): m/z calcd for C26H19ClN2NaO3 [M+Na]

























465.0976. IR υ max: 3064, 2918, 1699, 1657, 1593, 1256, 763, 700 cm-1. 
3'-(4-Bromophenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a
]pyrazole]-1,3,5'(3'H)-trione (3da) 
Prepared according to general procedure to afford 3da (122 mg, 
84% yield) as a white solid; m.p. 150-151 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.97 (d, J = 7.6 Hz, 1H), 7.74–7.70 (m, 
1H), 7.62–7.59 (m, 1H), 7.43 (d, J = 7.6 Hz, 1H), 7.29–7.26 (m, 
2H), 7.18–7.14 (m, 2H), 7.11–7.09 (m, 3H), 6.99–6.97 (m, 2H), 
5.73 (s, 1H), 4.39 (s, 1H), 3.85–3.80 (m, 1H), 3.08–3.03 (m, 
2H), 2.93–2.87 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 
197.9, 194.5, 172.7, 142.9, 141.2, 136.5, 135.8, 134.4, 131.6, 131.4, 128.9, 128.6, 
127.7, 127.6, 123.3, 121.9, 77.5, 71.9, 62.6, 48.1, 32.4; HRMS (ESI): m/z calcd for 
C26H19BrN2NaO3 [M+Na]
+ 509.0477, Found 509.0471. IR υ max: 3210, 2931, 1667, 
1589, 1485, 1396, 1273, 1069, 1011, 756, 694 cm-1. 
1'-Phenyl-3'-(4-(trifluoromethyl)phenyl)-6',7'-dihydro-1'H-spiro[indene-2,2'-pyr
azolo[1,2-a]pyrazole]-1,3,5'(3'H)-trione (3ea) 
Prepared according to general procedure to afford 3ea (131 mg, 
92% yield) as a white solid; m.p. 130-131 oC; For major 
diastereomer (dr = 4:1): 1H NMR (400 MHz, CDCl3) δ (ppm) 
8.01-7.96 (m, 1H), 7.80–7.71 (m, 1H), 7.68–7.59 (m, 1H), 7.44–
7.33 (m, 4H), 7.25–7.08 (m, 6H), 5.83 (s, 1H), 4.41 (s, 1H), 
3.87–3.80(m, 1H), 3.13–3.03 (m, 2H), 2.95–2.87 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ (ppm) 197.8, 194.4, 173.0, 142.9, 
141.2, 139.5, 136.5, 135.8, 131.2, 129.0, 128.6, 128.3, 127.8, 127.8, 126.5, 126.3, 
125.6(q, J = 3.7 Hz), 123.4, 123.3, 77.6, 72.0, 62.6, 47.9, 32.2; HRMS (ESI): m/z 
calcd for C27H20F3N2O3 [M+H]
+ 477.1426, Found 477.1421. IR υ max: 3063, 2930, 
1746, 1711, 1593, 1325, 1125, 768, 735, 700 cm-1. 
1'-Phenyl-3'-(p-tolyl)-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a]pyrazol
e]-1,3,5'(3'H)-trione (3fa) 
Prepared according to general procedure to afford 3fa (105 mg, 
83% yield) as a white solid; m.p. 153-154 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.96 (d, J = 7.6 Hz, 1H), 7.71–7.67 (m, 
1H), 7.57–7.54 (m, 1H), 7.39 (d, J = 7.6 Hz, 1H), 7.21–7.18 (m, 
2H), 7.11–7.08 (m, 3H), 6.97–6.92 (m, 4H), 5.78 (s, 1H), 4.41 
(s, 1H), 3.83–3.78 (m, 1H), 3.09–3.01 (m, 2H), 2.90–2.85 (m, 
1H), 2.17 (s, 3H); 13C NMR (100 MHz, CDCl3) δ (ppm) 198.3, 
194.8, 172.0, 143.1, 141.3, 137.5, 136.3, 135.6, 132.0, 131.6, 129.1, 128.8, 128.5, 
127.8, 125.6, 123.2, 123.1, 77.4, 72.1, 63.1, 48.5, 32.8, 21.1; HRMS (ESI): m/z calcd 
for C27H22N2NaO3 [M+Na]


























1701, 1653, 1258, 765 cm-1. 
3'-(3-Bromophenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a
]pyrazole]-1,3,5'(3'H)-trione (3ga) 
Prepared according to general procedure to afford 3ga (95 mg, 
65% yield) as a white solid; m.p. 171-172 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.98 (d, J = 7.6 Hz, 1H), 7.75–7.71 (m, 
1H), 7.63–7.59 (m, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.31–7.25 (m, 
2H), 7.18–7.16 (m, 2H), 7.10–7.09 (m, 3H), 7.02–6.95 (m, 2H), 
5.74 (s, 1H), 4.39 (s, 1H), 3.86–3.79 (m, 1H), 3.11–2.99 (m, 
2H), 2.93–2.85 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 197.9, 194.4, 173.3, 
143.0, 141.2, 137.8, 136.5, 135.8, 131.4, 131.1, 129.9, 129.1, 128.9, 128.5, 127.8, 
124.5, 123.4, 123.3, 122.8, 77.5, 71.9, 62.5, 47.7, 32.1; HRMS (ESI): m/z calcd for 
C26H19BrN2NaO3 [M+Na]
+ 509.0477, Found 509.0472. IR υ max: 3061, 2926, 1744, 
1709, 1593, 1260, 1236, 767, 733 cm-1. 
3'-(3-Nitrophenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a]
pyrazole]-1,3,5'(3'H)-trione (3ha) 
Prepared according to general procedure to afford 3ha (96 mg, 
71% yield) as a white solid; m.p. 166-168 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 8.04–7.98 (m, 3H), 7.77–7.73 (m, 1H), 
7.63–7.59 (m, 1H), 7.47–7.45 (m, 1H), 7.39–7.35 (m, 2H), 
7.17–7.09 (m, 5H), 5.85 (s, 1H), 4.40 (s, 1H), 3.89–3.83 (m, 
1H), 3.16–3.00 (m, 2H), 2.96–2.87 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ (ppm) 197.6, 194.5, 173.9, 148.2, 142.9, 141.1, 138.1, 136.7, 136.0, 
132.2, 131.2, 129.5, 129.1, 128.6, 127.8, 123.6, 123.3, 123.1, 121.3, 77.7, 71.9, 62.2, 
47.3, 31.7; HRMS (ESI): m/z calcd for C26H19N3NaO5 [M+Na]
+ 476.1222, Found 




Prepared according to general procedure to afford 3ia (117 mg, 
93% yield) as a white solid; m.p. 142-143 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.96 (d, J = 8.0 Hz, 1H), 7.72–7.68 (m, 
1H), 7.59–7.55 (m, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.20–7.18 (m, 
2H), 7.09–7.08 (m, 3H), 6.97–6.92 (m, 4H), 5.77 (s, 1H), 4.41 
(s, 1H), 3.83–3.78 (m, 1H), 3.10–3.00 (m, 2H), 2.91–2.85 (m, 
1H), 2.19 (s, 3H); 13C NMR (100 MHz, CDCl3) δ (ppm) 198.3, 194.8, 171.9, 143.1, 
141.3, 137.5, 136.3, 135.5, 132.0, 131.7, 129.2, 128.8, 128.5, 127.8, 125.6, 123.2, 
123.2, 77.4, 72.1, 63.2, 48.5, 32.8, 21.1; HRMS (ESI): m/z calcd for C27H22N2NaO3 


























1182, 766, 733, 700 cm-1. 
3'-(3-Methoxyphenyl)-1'-phenyl-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2
-a]pyrazole]-1,3,5'(3'H)-trione (3ja) 
Prepared according to general procedure to afford 3ja (108 mg, 
82% yield) as a white solid; m.p. 148-150 oC; For major 
diastereomer (dr = 7:1): 1H NMR (400 MHz, CDCl3) δ (ppm) 
7.97-7.95 (m, 1H), 7.73–7.69 (m, 1H), 7.61–7.57 (m, 1H), 7.43 
(d, J = 7.6 Hz, 1H), 7.20–7.04 (m, 6H), 6.67–6.59 (m, 3H), 5.77 
(s, 1H), 4.39 (s, 1H), 3.85–3.79 (m, 1H), 3.61 (s, 3H), 3.09–
3.02 (m, 2H), 2.92–2.87 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 198.3, 194.5, 
172.6, 159.6, 143.2, 141.2, 136.7, 136.3, 135.5, 131.6, 129.6, 128.9, 128.5, 127.8, 
125.7, 123.3, 118.1, 113.7, 111.3, 77.4, 71.9, 63.3, 55.1, 48.2, 32.5; HRMS (ESI): m/z 
calcd for C27H22N2NaO4 [M+Na]
+ 461.1477, Found 461.1472. IR υ max: 3059, 2932, 
1744, 1709, 1589, 1260, 1042, 768, 731, 698 cm-1. 
1'-Phenyl-3'-(thiophen-2-yl)-6',7'-dihydro-1'H-spiro[indene-2,2'-pyrazolo[1,2-a]p
yrazole]-1,3,5'(3'H)-trione (3ka) 
Prepared according to general procedure to afford 3ka (87 mg, 
70 % yield) as a white solid; m.p. 160-161 oC; 1H NMR (400 
MHz, CDCl3) δ (ppm) 7.97 (d, J = 8.0 Hz, 1H), 7.73–7.69 (m, 
1H), 7.59–7.55 (m, 1H), 7.39 (d, J = 7.6 Hz, 1H), 7.20–7.06 (m, 
8H), 5.81 (s, 1H), 4.42 (s, 1H), 3.85–3.79 (m, 1H), 3.10–3.03 
(m, 2H), 2.94–2.84 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
(ppm) 198.3, 194.7, 172.4, 143.1, 141.3, 136.3, 135.6, 135.1, 131.6, 128.9, 128.5, 
128.4, 127.9, 127.8, 125.7, 123.3, 123.2, 72.1, 63.3, 48.2, 32.6; HRMS (ESI): m/z 
calcd for C24H19N2O3S [M+H]
+ 415.1116, Found 415.1111. IR υ max: 2922, 2851, 
1701, 1657, 1593, 1256, 764 cm-1. 
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Crystal data and structure refinement for 3fa 
Identification code  shelx 
Empirical formula  C27H22N2O3 
Formula weight  422.46 
Temperature  293(2) K 
Wavelength  1.54187 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 9.34320(10) Å a= 113.841(8)°. 
 b = 11.3125(2) Å b= 108.881(8)°. 
 c = 12.1914(8) Å g = 96.208(7)°. 
Volume 1071.85(11) Å3 
Z 2 
Density (calculated) 1.309 Mg/m3 
Absorption coefficient 0.690 mm-1 
F(000) 444 
Crystal size 0.20 x 0.20 x 0.20 mm3 
Theta range for data collection 7.267 to 89.479°. 
Index ranges -11<=h<=11, -13<=k<=13, -14<=l<=14 
Reflections collected 12669 
Independent reflections 3796 [R(int) = 0.0440] 
Completeness to theta = 67.687° 96.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.871 and 0.637 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3796 / 0 / 290 
Goodness-of-fit on F2 1.141 
Final R indices [I>2sigma(I)] R1 = 0.0506, wR2 = 0.1244 
R indices (all data) R1 = 0.0558, wR2 = 0.1300 
Extinction coefficient n/a 
Largest diff. peak and hole 0.238 and -0.297 e.Å-3 
